Atlas Trials

Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer

Clinical trial NCT00039520 · COMPLETED

Trial details

NCT number
NCT00039520
Sponsor
Fox Chase Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2002-01-01
Primary completion
2004-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.